International spinal research trust research strategy. III: A discussion document

Spinal Cord

Volumn 45, Issue 1, 2007, Pages 2-14

  Adams, M ^a   Carlstedt, T ^b   Cavanagh, J ^a   Lemon, R N ^c   McKernan, R ^d   Priestley, J V ^e   Raisman, G ^c   Verhaagen, J ^f  

^a Bramley Business Centre   (United Kingdom)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

ISRT; Regeneration; Spinal cord injury

Indexed keywords

GANGLIOSIDE GM1; METHYLPREDNISOLONE; TETRACYCLINE DERIVATIVE;

CELL BASED GENE THERAPY; CELL DAMAGE; CELL DEATH; CELL TRANSPLANTATION; CLINICAL RESEARCH; ELECTROSTIMULATION THERAPY; HUMAN; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCAR; SCIENTIFIC LITERATURE; SPINAL CORD INJURY;

BIOMEDICAL RESEARCH; HUMANS; INTERNATIONAL COOPERATION; SPINAL CORD INJURIES; TRUST;

EID: 33846077692     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sj.sc.3101963     Document Type: Review

References (76)

1. Harper GP, Banyard PJ, Sharpe PC. The International Spinal Research Trust's strategic approach to the development of treatments for the repair of spinal cord injury. Spinal Cord 1996; 34: 449-459.
2. Ramer MS, Harper GP, Bradbury EJ. Progress in spinal cord research: a refined strategy for the international spinal research trust. Spinal Cord 2000; 38: 449-472.
3. McDonald JW, Sadowsky C. Spinal-cord injury. Lancet 2002; 359: 417-425.
4. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 2004; 15: 415-436.
5. Ramer LM, Ramer MS, Steeves JD. Setting the stage for functional repair of spinal cord injuries: a cast of thousands. Spinal Cord 2005; 43: 134-161.
6. Bracken MB et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998; 89: 699-706.
7. Geisler FH, Coleman WP, Grieco G, Poonian D. The Sygen multicenter acute spinal cord injury study. Spine 2001; 26: S87-S98.
8. Stirling DP et al. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 2004; 24: 2182-2190.
9. Leker RR, Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Brain Res Rev 2002; 39: 55-73.
10. Wahlgren NG, Ahmed N. Neuroprotection in cerebral ischaemia: facts and fancies - the need for new approaches. Cerebrovasc Dis 2004; 17: 153-166.
11. Anderson PN, Campbell G, Zhang Y, Lieberman AR. Cellular and molecular correlates of the regeneration of adult mammalian CNS axons into peripheral nerve grafts. Prog Brain Res 1998; 117: 211-232.
12. Schwab ME, Thoenen H. Dissociated neurons regenerate into sciatic but not optic nerve explants in culture irrespective of neurotrophic factors. J Neurosci 1985; 5: 2415-2423.
13. Schnell L, Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990; 343: 269-272.
14. Chen MS et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000; 403: 434-439.
15. Bareyre FM, Kerschensteiner M, Raineteau O, Mettenleiter TC, Weinmann O, Schwab ME. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci 2004; 7: 269-277.
16. McKeon RJ, Höke A, Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 1995; 136: 32-43.
17. Bradbury EJ et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636-640.
18. Bundesen LQ, Scheel TA, Bregman BS, Kromer LF. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J Neurosci 2003; 2: 7789-7800.
19. Willson CA, Miranda JD, Foster RD, Onifer SM, Whittemore SR. Transection of the adult rat spinal cord upregulates EphB3 receptor and ligand expression. Cell Transplant 2003; 12: 279-290.
20. Pasterkamp RJ et al. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol Cell Neurosci 1999; 13: 143-166.
21. Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003; 4: 703-713.
22. Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci 1997; 17: 5560-5572.
23. Ramer MS, Priestley JV, McMahon SB. Functional regeneration of sensory axons into the adult spinal cord. Nature 2000; 403: 312-316.
24. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003; 181: 115-129.
25. Bareyre FM, Schwab ME. Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci 2003; 26: 555-563.
26. Geller HM, Fawcett JW. Building a bridge: engineering spinal cord repair. Exp Neurol 2002; 174: 125-136.
27. King VR, Henseler M, Brown RA, Priestley JV. Mats made from fibronectin support oriented growth of axons in the damaged spinal cord of the adult rat. Exp Neurol 2003; 182: 383-398.
28. de Wit J, Verhaagen J. Role of semaphorins in the adult nervous system. Prog Neurobiol 2003; 71: 249-267.
29. Gallo G, Letourneau PC. Regulation of growth cone actin filaments by guidance cues. J Neurobiol 2004; 58: 92-102.
30. Skaper SD, Moore SE, Walsh FS. Cell signalling cascades regulating neuronal growth-promoting and inhibitory cues. Prog Neurobiol 2001; 65: 593-608.
31. Noga BR, Kriellaars DJ, Jordan LM. The effect of selective brainstem or spinal cord lesions on treadmill locomotion evoked by stimulation of the mesencephalic or pontomedullary locomotor regions. J Neurosci 1991; 11: 1691-1700.
32. Nathan PW. Effects on movement of surgical incisions into the human spinal cord. Brain 1991; 117: 337-346.
33. Blight AR. Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neuroscience 1983; 10: 521-543.
34. Eidelberg E, Story JL, Walden JG, Meyer BL. Anatomical correlates of return of locomotor function after partial spinal cord lesions in cats. Exp Brain Res 1981; 42: 81-88.
35. Hofstetter CP et al. A review of the neuropathology of human spinal cord injury with emphasis on special features. J Spinal Cord Med 1999; 22: 119-124.
36. Maegele M, Muller S, Wernig A, Edgerton VR, Harkema SJ. Recruitment of spinal motor pools during voluntary movements versus stepping after human spinal cord injury. J Neurotrauma 2002; 19: 1217-1229.
37. Dietz V. Proprioception and locomotor disorders. Nat Rev Neurosci 2002; 10: 781-790.
38. Dietz V, Muller R, Colombo G. Locomotor activity in spinal man: significance of afferent input from joint and load receptors. Brain 2002; 125: 2626-2634.
39. Wolpaw JR. Spinal Cord Plasticity: Alterations in Reflex Function. Kluwer Academic Publishers: Boston 2001.
40. Holler M, Hopf HC. Posttraumatic synkinesis of the diaphragm and muscles of the brachial plexus. Deut Zeit Nervenheilkund 1968; 193: 141-153.
41. Robinson PK. Associate movements between limb and respiratory muscles as a sequel to brachial plexus birth injury. Bull Johns Hopkins Hosp 1951; 89: 21-29.
42. Kew JJ et al. Abnormal access of axial vobrotactile input to deafferentated somatosensory cortex in human upper limb amputees. J Neurophysiol 1997; 77: 2753-2764.
43. Moore CI et al. Referred phantom sensation and cortical reorganisation after spinal cord injury in humans. Proc Natl Acad Sci USA 2000; 97: 14703-14708.
44. Banati RB. Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation? J Physiol Paris 2002; 96: 289-299.
45. Jain N, Florence SL, Kaas JH. Reorganisation of somatosensory cortex after nerve and spinal cord injury. News Physiol Sci 1998; 13: 143-149.
46. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 2002; 22: 6724-6731.
47. Turton AJ, Butler SR. Referred sensations following stroke. Neurocase 2001; 7: 397-405.
48. Borsook D et al. Acute plasticity in the human somatosensory cortex following amputation. Neuroreport 1998; 9: 1013-1017.
49. Kaas JH, Merzenich MM, Killackey HP. The reorganisation of somatosensory cortex following peripheral nerve damage in adult and developing mammals. Ann Rev Neurosci 1983; 6: 325-356.
50. Vroemen M, Aigner L, Winkler J, Weidner N. Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. Eur J Neurosci 2003; 18: 743-751.
51. Hill CE et al. Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration. Exp Neurol 2004; 190: 289-310.
52. Hofstetter CP et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005; 8: 346-353.
53. Akiyama Y, Radtke C, Kocsis JD. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 2002; 22: 6623-6630.
54. Hofstetter CP et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002; 99: 2199-2204.
55. Ankeny DP, McTigue DM, Jakeman LB. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol 2004; 190: 17-31.
56. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 2005; 191: 344-360.
57. Kamada T et al. Transplantation of bone marrow stromal cell-derived Schwann cells promotes axonal regeneration and functional recovery after complete transection of adult rat spinal cord. J Neuropathol Exp Neurol 2005; 64: 37-45.
58. Neuhuber B, Timothy Himes B, Shumsky JS, Gallo G, Fischer I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005; 1035: 73-85.
59. Barnett SC. Olfactory ensheathing cells: unique glial cell types? Neurotrauma 2004; 21: 375-382.
60. Raisman G. Olfactory ensheathing cells and repair of brain and spinal cord injuries. Cloning Stem Cells 2004; 6: 364-368.
61. Fouad K, Schnell L, Bunge MB, Schwab ME, Liebscher T, Pearse DD. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci 2005; 25: 1169-1178.
62. Blits B et al. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor. Exp Neurol 2004; 189: 303-316.
63. Ruitenberg MJ et al. Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury. Neurobiol Dis 2004; 15: 394-406.
64. Ruitenberg MJ, Hendriks WJT, Boer GJ, Verhaagen J. Gene therapy for spinal cord injury. In: Kaplitt MG, During M (eds). Gene Therapy in the Central Nervous System. Elsevier Inc.: Amsterdam 2006. pp 273-288.
65. Gaunt RA, Prochazka A. Control of urinary bladder function with devices: successes and failures. Prog Brain Res 2006; 152: 163-194.
66. Prochazka A, Mushahwar VK, McCreery DB. Neural prostheses. J Physiol 2001; 533: 99-109.
67. Balsubramanian AV, Wood S, Middleton FRI, Fowler C, Craggs MD. Urinary guarding reflex: aberrant in spinal cord injury? Br J Urol Int 2004; 9: 4.
68. Balsubramanian AV, Craggs MD, Fowler CJ. A neurophysiological and urodynamic assessment of residual supra-sacral sensory-motor pathways and their influence on aberrant lumbar-sacral reflexes in incomplete spinal cord injury. ISRT Annu Res Rev 2004; 9: 111-115.
69. Rodi Z, Vodusek DB. The sacral reflex studies:single versus double pulse electrical stimulation. Neurourol Urodyn 1995; 14: 496-497.
70. Curt A, Dietz V. Electrophysiological recordings in patients with spinal cord injury: significance for predicting outcome. Spinal Cord 1999; 37: 157-165.
71. Marshall LF et al. Deterioration following spinal cord injury. A multicenter study. J Neurosurg 1987; 66: 400-404.
72. Granovsky Y, Matre D, Sokolik A, Lorenz J, Casey KL. Thermoreceptive innervation of human glabrous and hairy skin: a contact heat evoked potential analysis. Pain 2005; 115: 238-247.
73. Steeves J, Fawcett J, Tuszynski M. Report of international clinical trials workshop on spinal cord injury February 20-21, 2004, Vancouver, Canada. Spinal Cord 2004; 42: 591-597.
74. Christopher Reeve Foundation. Can non-human primate experiments expedite translation of potential regenerative interventions following spinal cord injury to humans? in revision.
75. Edgerton VR, Roy RR, Hodgson JA, Prober RJ, de Guzman CP, de Leon R. Potential of adult mammalian lumbosacral spinal cord to execute and acquire improved locomotion in the absence of supraspinal input. J Neurotrauma 1992; 9: S119-S128.
76. Dietz V, Harkema SJ. Locomotor activity in spinal cord-injured persons. J Appl Physiol 2004; 96: 1954-1960.